Bromfenac Solution/ Drops
Product Images NDC 65862-789

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bromfenac (NDC 65862-789). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel 0.09% (1.7 mL Container) (Bromfenac Fig1)

Label for Bromfenac Ophthalmic Solution 0.09% (0.9 mg/mL) in a 1.7 mL bottle. The label indicates it is sterile, prescription only, for topical application in the eye once daily. Manufactured in India for Aurobindo Pharma USA, Inc., East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel 0.09% (1.7 mL Carton) (Bromfenac Fig2)

Packaging label for Bromfenac Ophthalmic Solution 0.09% (0.9 mg/mL) in a 1.7 mL topical eye drop solution by Aurobindo Pharma Limited. The label includes NDC 65862-789-17, lists active and inactive ingredients, storage instructions, dosage guidance, and manufacturer information. The label design incorporates text, barcodes, and the Aurobindo logo.*

FDA Label Image

Chemical Structure (Bromfenac Str)

Chemical structure of Bromfenac showing its molecular composition with a bromine-substituted aromatic ring, carboxyl sodium group, and water of hydration notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.